OREXIGEN THERAPEUTICS INC's ticker is and the CUSIP is 686164AB0.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $4,446,000 | -22.9% | 16,072,000 | 0.0% | 0.13% | -25.3% |
| Q2 2016 | $5,766,000 | -13.0% | 16,072,000 | 0.0% | 0.17% | -14.7% |
| Q1 2016 | $6,629,000 | -33.9% | 16,072,000 | -4.3% | 0.20% | -33.1% |
| Q4 2015 | $10,034,000 | -17.1% | 16,788,000 | -3.8% | 0.30% | -10.3% |
| Q3 2015 | $12,101,000 | -22.8% | 17,458,000 | 0.0% | 0.34% | -14.4% |
| Q2 2015 | $15,669,000 | -15.4% | 17,458,000 | +9.0% | 0.40% | -22.3% |
| Q1 2015 | $18,523,000 | +45.9% | 16,011,000 | +26.0% | 0.51% | +72.6% |
| Q4 2014 | $12,694,000 | – | 12,710,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 10,000,000 | $5,025,000 | 0.78% |
| GLG LLC | 4,960,000 | $2,480,000 | 0.15% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 7,500,000 | $3,000,000,000 | 0.05% |